{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T18:22:31Z","timestamp":1748197351522,"version":"3.37.3"},"reference-count":38,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2020,8,10]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Noninvasive ventilation (NIV) is considered as the first-line treatment for acute exacerbation of COPD (AECOPD) complicated by respiratory acidosis. Recent studies demonstrate a role of nasal high-flow oxygen (NHF) in AECOPD as an alternative treatment in patients intolerant to NIV or with contraindications to it.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>The study aimed to evaluate whether NHF respiratory support is noninferior compared to NIV in respect to treatment failure, defined as need for intubation or change to alternative treatment group, in patients with AECOPD and mild-to-moderate acute or acute-on-chronic hypercapnic respiratory failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We designed a multicentre, prospective, randomised trial on patients with AECOPD, who have pH&lt;7.35 but &gt;7.25 and<jats:italic>P<\/jats:italic><jats:sub>aCO<jats:sub>2<\/jats:sub><\/jats:sub>\u2005&gt;45\u2005mmHg, in whom NIV is indicated as a first-line treatment. According to power analysis, 498 participants will be required for establishing noninferiority of NHF compared to NIV. Patients will be randomly assigned to receive NIV or NHF. Treatment will be adjusted to maintain<jats:italic>S<\/jats:italic><jats:sub>pO<jats:sub>2<\/jats:sub><\/jats:sub>between 88%\u201392% for both groups. Arterial blood gases, respiratory variables, comfort, dyspnoea score and any pulmonary or extrapulmonary complications will be assessed at baseline, before treatment initiation, and at 1, 2, 4, 6, 12, 24, 48\u2005h, then once daily from day 3 to patient discharge, intubation or death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Given the increasing number of studies demonstrating the physiological effects of NHF in COPD patients, we hypothesise that NHF respiratory support will be noninferior to NIV in patients with AECOPD and mild-to-moderate acute or acute on chronic hypercapnic respiratory failure.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00114-2020","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T12:55:10Z","timestamp":1603112110000},"page":"00114-2020","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Nasal high-flow oxygen<i>versus<\/i>noninvasive ventilation in acute exacerbation of COPD: protocol for a randomised noninferiority clinical trial"],"prefix":"10.1183","volume":"6","author":[{"given":"Athanasia","family":"Papalampidou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Bibaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stylianos","family":"Boutlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8846-519X","authenticated-orcid":false,"given":"Ioannis","family":"Pantazopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Moylan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Vlachakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Grigoropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Eleftheriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Daniil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Gourgoulianis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Kalomenidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros","family":"Zakynthinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Ischaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"2024101708022990000_6.4.00114-2020.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00164-2019"},{"key":"2024101708022990000_6.4.00114-2020.2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.041830"},{"key":"2024101708022990000_6.4.00114-2020.3","first-page":"471","article-title":"Non-invasive ventilation in exacerbations of COPD","volume":"2","author":"Ambrosino","year":"2007","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101708022990000_6.4.00114-2020.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-005-0050-0"},{"key":"2024101708022990000_6.4.00114-2020.5","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.02456"},{"key":"2024101708022990000_6.4.00114-2020.6","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2015-208209","article-title":"BTS\/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults","volume":"71: Suppl 2","author":"Davidson","year":"2016","journal-title":"Thorax"},{"key":"2024101708022990000_6.4.00114-2020.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-2871"},{"key":"2024101708022990000_6.4.00114-2020.8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.201605-0916OC","article-title":"Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure","volume":"195","author":"Mauri","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101708022990000_6.4.00114-2020.9","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0028-2017"},{"key":"2024101708022990000_6.4.00114-2020.10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00134-019-05658-2","article-title":"High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis","volume":"45","author":"Rochwerg","year":"2019","journal-title":"Intensive Care Med"},{"key":"2024101708022990000_6.4.00114-2020.11","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00279.2016"},{"key":"2024101708022990000_6.4.00114-2020.12","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207962"},{"key":"2024101708022990000_6.4.00114-2020.13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/COPD.S159666","article-title":"Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure","volume":"13","author":"Storgaard","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101708022990000_6.4.00114-2020.14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1513\/AnnalsATS.201706-425OC","article-title":"Domiciliary high-flow nasal cannula oxygen therapy for patients with stable hypercapnic chronic obstructive pulmonary disease. a multicenter randomized crossover trial","volume":"15","author":"Nagata","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2024101708022990000_6.4.00114-2020.15","first-page":"87","article-title":"Nasal high-flow therapy for type II respiratory failure in COPD: A report of four cases","volume":"20","author":"Pavlov","year":"2017","journal-title":"Respir Med Case Rep"},{"key":"2024101708022990000_6.4.00114-2020.16","doi-asserted-by":"publisher","DOI":"10.1177\/1753465814521890"},{"key":"2024101708022990000_6.4.00114-2020.17","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.2147\/COPD.S185001","article-title":"Nasal high-flow in acute hypercapnic exacerbation of COPD","volume":"13","author":"Br\u00e4unlich","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101708022990000_6.4.00114-2020.18","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.9.708"},{"key":"2024101708022990000_6.4.00114-2020.19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15412555.2020.1715361","article-title":"Nasal high flow use in COPD patients with hypercapnic respiratory failure: treatment algorithm and review of the literature","volume":"17","author":"Pantazopoulos","year":"2020","journal-title":"COPD"},{"key":"2024101708022990000_6.4.00114-2020.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0099-1767(00)90093-X"},{"key":"2024101708022990000_6.4.00114-2020.21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1590\/S1806-37132010000500008","article-title":"Dyspnea in COPD: beyond the modified Medical Research Council scale","volume":"36","author":"Camargo","year":"2010","journal-title":"J Bras Pneumol"},{"key":"2024101708022990000_6.4.00114-2020.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201402-0364OC"},{"key":"2024101708022990000_6.4.00114-2020.23","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1263-z"},{"key":"2024101708022990000_6.4.00114-2020.24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/jamp.2015.1219","article-title":"Aerosol therapy in adults receiving high flow nasal cannula oxygen therapy","volume":"29","author":"R\u00e9miniac","year":"2016","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"Suppl 1","key":"2024101708022990000_6.4.00114-2020.25","first-page":"S12","article-title":"High-flow nasal cannula, is there a role in COPD?","volume":"16","author":"Hill","year":"2017","journal-title":"Tanaffos"},{"key":"2024101708022990000_6.4.00114-2020.26","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S104616"},{"key":"2024101708022990000_6.4.00114-2020.27","first-page":"259","article-title":"Editorial: sorting out the mechanisms of benefit of high flow nasal cannula in stable COPD","volume":"4","author":"Criner","year":"2017","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2024101708022990000_6.4.00114-2020.28","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.01.125"},{"key":"2024101708022990000_6.4.00114-2020.29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5935\/0103-507X.20190026","article-title":"Efficacy and safety of high-flow nasal cannula oxygen therapy in moderate acute hypercapnic respiratory failure","volume":"31","author":"Yuste","year":"2019","journal-title":"Rev Bras Ter Intensiva"},{"key":"2024101708022990000_6.4.00114-2020.30","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04220"},{"key":"2024101708022990000_6.4.00114-2020.31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.5213"},{"key":"2024101708022990000_6.4.00114-2020.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.14194"},{"key":"2024101708022990000_6.4.00114-2020.33","doi-asserted-by":"publisher","DOI":"10.1111\/crj.12772"},{"key":"2024101708022990000_6.4.00114-2020.34","first-page":"837","article-title":"Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation","volume":"55","author":"Ari","year":"2010","journal-title":"Respir Care"},{"key":"2024101708022990000_6.4.00114-2020.35","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.05127"},{"key":"2024101708022990000_6.4.00114-2020.36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13613-018-0473-8","article-title":"Nasal high-flow bronchodilator nebulization: a cross-over study","volume":"8","author":"R\u00e9miniac","year":"2018","journal-title":"Ann Intensive Care"},{"key":"2024101708022990000_6.4.00114-2020.37","doi-asserted-by":"publisher","DOI":"10.2345\/0899-8205-45.1.69"},{"key":"2024101708022990000_6.4.00114-2020.38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/thx.52.2.171","article-title":"Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask","volume":"52","author":"Parkes","year":"1997","journal-title":"Thorax"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00114-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:04:32Z","timestamp":1740373472000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00114-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,10,19]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1183\/23120541.00114-2020"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00114-2020","relation":{},"ISSN":["2312-0541"],"issn-type":[{"type":"electronic","value":"2312-0541"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}